Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Non Operating Investment Income (2024)

Historic Non Operating Investment Income for Tonix Pharmaceuticals Holding (TNXP) over the last 1 years, with Q2 2024 value amounting to -$855000.0.

  • Tonix Pharmaceuticals Holding's Non Operating Investment Income changed N/A to -$855000.0 in Q2 2024 from the same period last year, while for Dec 2024 it was $6.1 million, marking a year-over-year change of. This contributed to the annual value of $6.1 million for FY2024, which is N/A changed from last year.
  • Tonix Pharmaceuticals Holding's Non Operating Investment Income amounted to -$855000.0 in Q2 2024.
  • Tonix Pharmaceuticals Holding's Non Operating Investment Income's 5-year high stood at $7.0 million during Q1 2024, with a 5-year trough of -$855000.0 in Q2 2024.